Prr seem to have been developing nicely and although a biased opinion managemnet claims that the value of their intellectual property far exceeds the current share price. Their portfolio of research projects focus on the following areas: -technology that has the potential to both prevent and treat Malaria -development of tumour antigens to target cancer cells of the breast, lungs, colon, ovaries and prostate -development of new drugs for rheumatoid athritis -producing an immune response in large animals leading to a vaccination against foot and mouth disease. Several licences and royalties in the pipeline with significant announcements due in July. Worth a punt at current levels, who knows how this one may run if any one of their technologies is a hit.
PRR Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)